Evidence map›Paper›PMID 36980364›Full record

ReviewDiagnostics (Basel, Switzerland)2023

Human Anthrax: Update of the Diagnosis and Treatment.

Mehmet Doganay, Gokcen Dinc, Ainura Kutmanova, Les Baillie

Open access · goldFull text readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 54 citations in OpenAlex.

  1. Cutaneous Anthrax.Clinical practice and cases in emergency medicine · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Anthrax meningoencephalitis: A case report.Experimental and therapeutic medicine · 2025
    Article
  14. Article
  15. Article
  16. Anthrax: A narrative review.New microbes and new infections · 2024
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 3 countries.

Mehmet DoganayDepartment of Infectious Diseases, Faculty of Medicine, Lokman Hekim University, 06510 Ankara, Turkey.ORCID 0000-0003-3922-4901
Gokcen DincDepartment of Medical Microbiology, Faculty of Medicine, Erciyes University, 38039 Kayseri, Turkey.ORCID 0000-0002-9184-5003
Ainura KutmanovaDepartment of Infectious Diseases, International Higher School of Medicine, Bishkek 720010, Kyrgyzstan.
Les BaillieSchool of Pharmacy and Pharmaceutical Science, College of Biomedical and Life Sciences, Cardiff University, Cardiff CF10 3NB, UK.
Cardiff University · GBErciyes University · TRInternational University of Kyrgyzstan · KGLokman Hekim Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anthrax is one of the most important zoonotic diseases which primarily infects herbivores and occasionally humans. The etiological agent is

Indexed as

anthraxclinical featuresdiagnosisepidemiologytreatment

Identifiers

PMID36980364
PMCPMC10046981
OpenAlexW4323849243

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read29
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.